Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy
Study Information
Alliance Study ID: CALGB-60102
NCT Study ID (ClinicalTrials.gov): NCT00048971
Alliance Committee: Experimental Therapeutics
Disease or Cancer Type: Colorectal / Colon / Rectal Cancer
Alliance Study Chair: Mark J. Ratain, MD
Status: COMPLETED
Study Description
RATIONALE: Genetic testing may help predict how patients will respond to chemotherapy drugs and may help doctors plan more effective treatment with fewer side effects.
PURPOSE: Genetic study to determine how genes affect the severity of diarrhea in patients with stage III colon cancer who are receiving chemotherapy.
Related Publications
For publications related to this and other clinical trials, visit the Alliance Publications Application.
Data Sources & Contacts
Full trial details
For more Information